Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification
- 1 August 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (15), 7749-7760
- https://doi.org/10.1128/jvi.00108-09
Abstract
Epstein-Barr virus (EBV) is associated with malignant diseases of lymphoid and epithelial cell origin. The tropism of EBV is due to B-cell-restricted expression of CD21, the major receptor molecule for the virus. However, efficient infection of CD21 − epithelial cells can be achieved via transfer from EBV-coated B cells. We compare and contrast here the early events following in vitro infection of primary B cells and epithelial cells. Using sensitive, quantitative reverse transcription-PCR assays for several latent and lytic transcripts and two-color immunofluorescence staining to analyze expression at the single cell level, we confirmed and extended previous reports indicating that the two cell types support different patterns of transcription. Furthermore, whereas infection of B cells with one or two copies of EBV resulted in rapid amplification of the viral genome to >20 copies per cell, such amplification was not normally observed after infection of primary epithelial cells or undifferentiated epithelial lines. In epithelial cells, EBNA1 expression was detected in only ca. 40% of EBER + cells, and the EBV genome was subsequently lost during prolonged culture. One exception was that infection of AGS, a gastric carcinoma line, resulted in maintenance of EBNA1 expression and amplification of the EBV episome. In contrast to B cells, where amplification of the EBV episome occurred even with a replication-defective BZLF1-knockout virus, amplification in AGS cells was dependent upon early lytic cycle gene expression. These data highlight the influence of the host cell on the outcome of EBV infection with regard to genome expression, amplification, and maintenance.This publication has 58 references indexed in Scilit:
- An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survivalThe Journal of Experimental Medicine, 2008
- Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinomaInternational Journal of Cancer, 2008
- Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survivalBlood, 2007
- Analysis of Epstein–Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assaysJournal of General Virology, 2006
- Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Epstein–Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowthJournal of General Virology, 2005
- Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth TransformationJournal of Virology, 2005
- Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial Cell Cultures of Asymptomatic CarriersJournal of Virology, 2004
- Epstein–Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathwayOncogene, 2004
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsThe New England Journal of Medicine, 1984